Preventric Diagnostics, Inc.

A data revolution in blood pressure measurement


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9


Preventric uses its cuffless & wrist worn BPro technology and advanced blood pressure data to revolutionize the experience of diagnosing and managing hypertension while creating new digital biomarkers to predict vascular disease progression. We are improving patient outcomes and financial savings, serving the ne

eds of patients, physicians, and payers, and creating a new "Digital Standard of Care."


The cuff-less BPro is the only non-intrusive 24- Ambulatory Monitoring (ABPM) device built to close these BP gaps in care with 500x more BP data than other methods combined.

BPro delivers precise and accurate determination of hypertension and risk of vascular-related diseases such as dementia, stroke, kidney, and other inflammatory disorders.

BPro creates new insights that allow physicians to proactively manage patients that are being over or undertreated for hypertensive-related disorders, using Preventric data to target precise prescription drug changes.



Our patented BPro technology measures “central blood pressure" and “arterial stiffness,” with a 99.17% accuracy rate compared to an invasive arterial catheter.  BPro providing  advanced medical data never seen before, to include the following:


BPro technology has been proven to work as represented by intellectual property protection by 7 US patents, proprietary algorithms, source code   and trade secrets. Clinically, the BPro has been cited in 70+ peer-reviewed studies and has undergone 21 clinical trials with 20,000+ patients.

Strategic Alliances

J.P. Morgan Chase (Life Science Accelerator Program)

American Heart Association (Center for Health Technology and Innovation)

Bayer Pharmaceuticals – Pressure Smart Program

Syneos (commercialization partner)

EPAM (development of the Vascular Health Intelligence platform)

We have already commercialized our wearable, non-invasive, sensor-based, and cuffless BP monitor known as the BPro that some have said will be one of the holy grails of medical technology development. We have several contracts with physician offices.


In September, the Kaiser Permanente Research Institute released a survey stating,


The Preventric team has over 120 years of healthcare experience, talent, and passion. The challenge is enormous, but we derive satisfaction in knowing we are driving transformative care for vascular disease patients. Our future strategies will be implemented with mission-driven, service-line growth, and market disruption in mind.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.